Pharma Reimbursement & Market Access 2015 covers topics such as:
- How to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
- When, where and how Comparative Effectiveness Research should be factored into a drug manufacturers overall market access strategy
- Key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
- How to use HTA to create payer evidence: The role of postapproval programs
- Insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
- The evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
- The current state of affairs: Post midterm elections in the exchange marketplaceand the impact on drug positioning
- Anticipate the implementation of ICD-10 and the underlying effect on product
- Your engagement model: The new look of pharma/ biopharma/payer relationship
Pharma Reimbursement & Market Access 2015 brings together attendees from:
- Outcome Research
- Health Economics
- Effectiveness Research
- Comparative
- Brand Access
- Pricing
- Commercialization
- Market Access
- Outcomes
- Payer Relationships
- Marketing Commercialization
- Patient-Reported Outcomes
- Outcomes, Liaison, Access Solutions
